Article Details

AbCellera Biologics Target of Unusually High Options Trading (NASDAQ:ABCL)

Retrieved on: 2022-10-22 11:35:50

Tags for this article:

Click the tags to see associated articles and topics

AbCellera Biologics Target of Unusually High Options Trading (NASDAQ:ABCL). View article details on hiswai:

Excerpt

Traders bought 3,135 call options on the company. This is an increase of approximately 125% compared to the average volume of 1,391 call options. Wall ...

Article found on: reporter.am

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up